Inhibition of aflatoxin B1 mutagenicity by cyclopiazonic acid in the presence of human liver preparations

Toxicology Letters

Volumn 143, Issue 3, 2003, Pages 291-299

  Sabater Vilar, Monica ^a   Kuilman Wahls, Mariella E M ^a   Fink Gremmels, Johanna ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Aflatoxin B1; Cyclopiazonic acid; Cytochrome P450; Mutagenicity

Indexed keywords

AFLATOXIN B1; CYCLOPIAZONIC ACID; CYTOCHROME P450 3A4; METHOXYRESORUFIN; RESORUFIN DERIVATIVE; TESTOSTERONE; UNCLASSIFIED DRUG; CYTOCHROME P450; CYTOCHROME P450 1A2; ENZYME INHIBITOR; INDOLE DERIVATIVE; LIVER EXTRACT; METHOXYRESORUFIN O DEMETHYLASE; METHOXYRESORUFIN-O-DEMETHYLASE; MUTAGENIC AGENT; OXIDOREDUCTASE; TISSUE EXTRACT;

AMES TEST; ARTICLE; CONTROLLED STUDY; DEALKYLATION; DRUG EFFECT; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; HYDROXYLATION; LIVER TOXICITY; METABOLIC ACTIVATION; MUTAGENICITY; PRIORITY JOURNAL; CHEMISTRY; DRUG ANTAGONISM; ENZYME INDUCTION; LIVER; METABOLISM; MUTAGEN TESTING; PHYSIOLOGY;

SALMONELLA;

AFLATOXIN B1; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ENZYME INHIBITORS; HUMANS; INDOLES; LIVER; LIVER EXTRACTS; MUTAGENICITY TESTS; MUTAGENS; OXIDOREDUCTASES; TESTOSTERONE; TISSUE EXTRACTS;

EID: 0038802578     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(03)00196-6     Document Type: Article

References (50)

1. Ames B.M., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31:1975;347-363.
2. Asgrimsson H.J., Wohlfart B., Brandt J., Johannsson M. Effects of [Na+]o, [Ca2+]o and cyclopiazonic acid on decline of post-extrasystolic potentiation and twitch kinetics in guinea-pig and human myocardial preparations. Acta Physiol. Scand. 166:(3):1999;195-201.
3. Balachandran C., Parthasarathy K.R. Occurrence of cyclopiazonic acid in feeds and feedstuffs in Tamil Nadu, India. Mycopathologia. 133:(3):1996;159-162.
4. Beaune P., Lemestre-Cornet R., Kremers P., Albert A., Gielen J. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems. Mutat. Res. 156:(3):1985;139-146.
5. Burke M.C., Mayer R.T. Ethoxyresorufin: direct fluorometric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2:1974;583-588.
6. Byrem T.M., Pestka J.J., Chu F.S., Strasburg G.M. Analysis and pharmacokinetics of cyclopiazonic acid in market weight pigs. J. Anim. Sci. 77:(1):1999;173-179.
7. Dorner J.W., Cole R.J., Erlington D.J., Suksupath S., McDowell G.H., Bryden W.L. Cyclopiazonic acid residues in milk and eggs. J. Agric. Food Chem. 42:1994;1516-1518.
8. Draper A.J., Madan A., Smith K., Parkinson A. Development of a non-high pressure liquid chromatography assay to determine testosterone hydroxylase (CYP3A) activity in human liver microsomes. Drug Metab. Dispos. 26:(4):1998;299-304.
9. Eaton D.L., Gallagher E.P. Mechanisms of aflatoxins carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 34:1994;135-172.
10. Egner P.A., Wang J.B., Zhu Y.R., Zhang B.C., Wu Y., Zhang Q.N., Qian G.S., Kuang S.Y., Gange S.J., Jacobson L.P., Helzlsouer K.J., Bailey G.S., Groopman J.D., Kensler T.W. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. USA. 98:(25):2001;14601-14606.
11. Ethier M.F., Yamaguchi H., Madison J.M. Effects of cyclopiazonic acid on cytosolic calcium in bovine airway smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 281:(1):2001;L126-133.
12. Fernandez-Pinto V., Patriarca A., Locani O., Vaamonde G. Natural co-occurrence of aflatoxin and cyclopiazonic acid in peanuts grown in Argentina. Food Addit. Contam. 18:(11):2001;1017-1020.
13. Forrester L.M., Neal G.E., Judah D.J., Glancey M.J., Wolf C.R. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Proc. Natl. Acad. Sci. USA. 87:(21):1990;8306-8310.
14. Gallagher E.P., Kunze K.L., Stapleton P.L., Eaton D.L. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol. Appl. Pharmacol. 141:(2):1996;595-606.
15. Gentles A., Smith E.E., Kubena L.F., Duffus E., Johnson P., Thompson J., Harvey R.B., Edrington T.S. Toxicological evaluations of cyclopiazonic acid and ochratoxin A in broilers. Poult. Sci. 78:(10):1999;1380-1384.
16. Gqaleni N., Smith J.E., Lacey J. Co-production of aflatoxins and cyclopiazonic acid in isolates of Aspergillus flavus. Food Addit. Contam. 13:(6):1996;677-685.
17. Goto T., Wicklow D.T., Ito Y. Aflatoxin and cyclopiazonic acid production by a sclerotium-producing Aspergillus tamarii strain. Appl. Environ. Microbiol. 62:(11):1996;4036-4038.
18. Guengerich F.P. Forging the links between metabolism and carcinogenesis. Mutat. Res. 488:(3):2001;195-209.
19. 1. Chemico. Biol. Interact. 111-112:1998;51-67.
20. Hoebel B.G., Kostner G.M., Graier W.F. Activation of microsomal cytochrome P450 mono-oxygenase by Ca+2 store depletion and its contribution to Ca+2 entry in porcine aortic endothelial cells. Br. J. Pharmacol. 121:1997;1579-1588.
21. Holzapfel C.W. The isolation and structure of cyclopiazonic acid, a toxic metabolite of Penicillium cyclopium Westling. Tetrahedron. 24:1968;2101-2119.
22. 1 and cyclopiazonic acid by soil isolates of Aspergillus flavus along a transect within the United States. Appl. Environ. Microbiol. 65:(4):1999;1444-1449.
23. Huang X., Dorner J.W., Chu F.S. Production of aflatoxin and cyclopiazonic acid by various Aspergilli: an ELISA analysis. Mycotox. Res. 10:1994;101-106.
24. Kensler T.W., He X., Otieno M., Egner P.A., Jacobson L.P., Chen B., Wang J.S., Zhu Y.R., Zhang B.C., Wang J.B., Wu Y., Zhang Q.N., Qian G.S., Kuang S.Y., Fang X., Li Y.F., Yu L.Y., Prochaska H.J., Davidson N.E., Gordon G.B., Gorman M.B., Zarba A., Enger C., Munoz A., Helzlsouer K.J., et al. Oltipraz chemoprevention trial in Qidong, People's Republic of China: modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomark. Prev. 7:(2):1998;127-134.
25. Kuilman M.E.M., Sabater-Vilar M., de Nijs-Tjon L., Maas R.F.M., Fink-Gremmels J. Cyclopiazonic acid inhibits mutagenic action of aflatoxin B1. Environ. Toxicol. Pharmacol. 11:2002;207-212.
26. 1 in the Salmonella microsuspension assay. Mutat. Res. 398:(1-2):1998;183-187.
27. 1 biotransformation. J. Agric. Food Chem. 49:(11):2001;5171-5177.
28. Lipscomb J.C., Kedderis G.L. Incorporating human inter-individual biotransformation variance in health risk assessment. Sci. Total Environ. 288:(1-2):2002;13-21.
29. 1 in the rat. Toxicol. Appl. Pharmacol. 93:(3):1988;442-451.
30. Lowry O.H., Rosebourg N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
31. Luk H.C., Kobbe B., Townsend J.M. Production of cyclopiazonic acid by Aspergillus flavus Link. Appl. Environ. Microbiol. 33:(1):1977;211-212.
32. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. May. 1/3:1983;173-215.
33. Martins M.L., Martins H.M. Natural and in vitro coproduction of cyclopiazonic acid and aflatoxins. J. Food Prot. 62:(3):1999;292-294.
34. Micco C., Brera C., Miraglia M., Onori R. HPLC determination of the total content of aflatoxins in naturally contaminated eggs in free and conjugate forms. Food Addit. Contam. 4:(4):1987;407-414.
35. Nishie K. Toxicity and neuropharmacology of cyclopiazonic acid. Food Chem. Toxicol. 23:(9):1985;831-839.
36. Norred W.P., Porter J.K., Dorner J.W., Cole R.J. Occurrence of the mycotoxin cyclopiazonic acid in meat after oral administration to chickens. J. Agric. Food Chem. 36:1986;113-116.
37. Norpoth K., Grossmeier R., Bosenberg H., Themann H., Fleischer M. Mutagenicity of aflatoxin B1, activated by S9 fractions of human, rat, mouse, rabbit, and monkey liver, towards S. typhimurium TA 98. Int. Arch. Occup. Environ. Health. 42:(3-4):1979;333-339.
38. OCDE/OECD guidelines, 1998. Ninth Addemium to the OECD Guidelines for the testing of chemicals: Bacterial Reverse Mutation test. 471.
39. 1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Res. 50:(3):1990;615-620.
40. Raney K.D., Meyer D.J., Ketterer B., Harris T.M., Guengerich F.P. Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol. 5:(4):1992;470-478.
41. Schwinger R.H., Brixius K., Bavendiek U., Hoischen S., Muller-Ehmsen J., Bolck B., Erdmann E. Effect of cyclopiazonic acid on the force-frequency relationship in human nonfailing myocardium. J. Pharmacol. Exp. Ther. 283:(1):1997;286-292.
42. Stoner G.D., Mukhtar H. Polyphenols as cancer chemopreventive agent. J. Cell Biochem. 22:1995;169-180.
43. 1 in blood and milk of cows given aflatoxin B1. Am. J. Vet. Res. 44:(9):1983;1753-1756.
44. Urano T., Trucksess M.W., Beaver R.W., Wilson D.M., Dorner J.W., Dowell F.E. Co-occurrence of cyclopiazonic acid and aflatoxins in corn and peanuts. J. AOAC Int. 75:1992;838-841.
45. 1 by oltipraz in residents of Qidong, People's Republic of China. J. Natl. Cancer Inst. 91:(4):1999;347-354.
46. Waters M.D., Brady A.L., Stack H.F., Brockman H.E. Anti-mutagenicity profiles for some model compounds. Mutat. Res. 238:1990;57-85.
47. Widiastuti R., Maryam R., Blaney B.J., Salfina, Stoltz D.R. Cyclopiazonic acid in combination with aflatoxins, zearalenone and ochratoxin A in Indonesian corn. Mycopathologia. 104:1988;153-156.
48. Wild C.P., Hall A.J. The epidemiology of mycotoxin-related disease. Howard D.H., Miller J.D. The Mycota (III), Animal and Human Relationships. 1995;Springer, New York.
49. Wortelboer H.M., de Kruif C.A., van Iersel A.A., Falke H.E., Noordhoek J., Blaauboer B.J. The isoenzyme pattern of cytochrome P450 in rat hepatocytes in primary culture, comparing different enzyme activities in microsomal incubations and in intact monolayers. Biochem. Pharmacol. 40:(11):1990;2525-2534.
50. Yamazaki H., Shimada T. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Arch. Biochem. Biophys. 346:(1):1997;161-169.